{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Veliparib (ABT-888)",
        "type": {
          "id": "6b7be201-db4f-4109-9436-bcdfec1c4073",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "432c37ff-3460-4385-bf1d-6a9e28463882",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "PARP inhibitor for HER2-negative metastatic or locally advanced unresectable BRCA-associated breast cancer.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "648bdcbf-569d-4fea-8810-c5f81b40d1d3",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "72ae2e86-f831-4700-af6a-3dc8ce9326dc",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for veliparib.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Carboplatin",
        "type": {
          "id": "440e36e3-ddf1-42ca-abf9-a7714034c6d2",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "e4a4431b-30e1-4a22-ac27-640fe6b3ad6a",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Cytotoxic chemotherapy administered as reference therapy.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Paclitaxel",
        "type": {
          "id": "e4713708-7ba2-46a9-b944-fa68f63eb14e",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "9521463b-2276-4247-854e-0fa7f433fbaf",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Cytotoxic chemotherapy administered as reference therapy.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "2a5460e8-e5bd-42e2-8286-186149019bbc",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0aa1ad1b-a184-410d-9040-c7e930eb43c0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions.",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "Diphenhydramine",
        "type": {
          "id": "f3452204-5963-406a-94c1-434d20d8c47a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2813ed40-de7c-474f-915f-2dee673a7212",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "id": "int_7",
        "name": "H2 antagonists",
        "type": {
          "id": "16a2484d-ea57-4576-89b8-29bb920bed76",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "44e1b533-713f-410a-817e-07b601a92cee",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "id": "int_8",
        "name": "Palonosetron",
        "type": {
          "id": "ffe9aa2b-434a-46be-badd-77558c8d884c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0d478b42-6a87-4327-bca5-dce5c6e86848",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "id": "int_9",
        "name": "Dexamethasone",
        "type": {
          "id": "7cd4569a-2065-4eaa-84eb-e3da58229190",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "bf604695-2238-4d85-877d-514b2e178118",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "id": "int_10",
        "name": "Aprepitant",
        "type": {
          "id": "97071b40-e85c-4560-ae6a-3c0768720aa8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8b5f19a6-9a1f-4d46-ad31-97cce1fa4856",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Optional antiemetic."
      },
      {
        "id": "int_11",
        "name": "G-CSF",
        "type": {
          "id": "7594344c-2d64-4741-bcf8-b332535a2661",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "e4ce686d-864d-4603-b38c-f63f921a6f12",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Colony stimulating factor permitted for supportive care or to maintain dose intensity."
      },
      {
        "id": "int_12",
        "name": "Bisphosphonates",
        "type": {
          "id": "5b779aa2-8f8e-4569-b165-513f57594067",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b083ed79-ca38-491b-a94e-be6f087a42c1",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for osteoporosis or bone metastases management; prohibited for anti-cancer effect."
      },
      {
        "id": "int_13",
        "name": "Denosumab",
        "type": {
          "id": "0e328da1-6b3f-47a0-b920-959a91fad27c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "e700d718-fc82-4fae-9cd6-807c7c840620",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for management of bone metastases."
      },
      {
        "id": "int_14",
        "name": "Anticancer hormonal therapy",
        "type": {
          "id": "60cf438b-aa52-4d59-91ee-31831927d83a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2669d62a-91f7-45ea-991c-168b48ffe054",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited during the study; must be stopped 7 days before starting C1D-2."
      },
      {
        "id": "int_15",
        "name": "Chinese medicine/herbals",
        "type": {
          "id": "80f5e45d-5421-4253-9fa8-b2c447b71345",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0b99f3d5-48d6-460e-8013-12d6a8e09be9",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited; requires a 14-day washout period."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Veliparib",
        "administrableDoseForm": {
          "id": "224d3495-2f2a-4462-a140-04fa399a61c8",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "9a68b4fa-4e19-48a4-911c-ed22ff98ef54",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "cc7b6e85-0299-4fdc-b81d-220352173495",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_2",
        "name": "Carboplatin",
        "administrableDoseForm": {
          "id": "d686e08b-17d4-4e82-846b-ae0b6cc8fbcc",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "de2b85d2-373e-4776-9063-96dbda2a3832",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "a889f6c5-03ab-4de1-a2d4-0b92f8a57348",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "d5ef88d8-0044-4067-9ab6-021c3210400b",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "1fc73185-03d2-4720-a927-ca67e3eb7369",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "1c1f9a51-f742-4f6d-8d79-fa0d22e307e3",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Veliparib/Placebo Combination Phase",
        "instanceType": "Administration",
        "dose": "120 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days -2 through 5 of a 21-day cycle"
      },
      {
        "id": "admin_2",
        "name": "Carboplatin",
        "instanceType": "Administration",
        "dose": "AUC 6",
        "doseFrequency": "once per cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Day 1 of a 21-day cycle"
      },
      {
        "id": "admin_3",
        "name": "Paclitaxel",
        "instanceType": "Administration",
        "dose": "80 mg/m2",
        "doseFrequency": "weekly",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Days 1, 8, and 15 of a 21-day cycle"
      },
      {
        "id": "admin_4",
        "name": "Veliparib/Placebo Single-Agent Phase (Starting)",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days 1 through 21 of a 21-day cycle"
      },
      {
        "id": "admin_5",
        "name": "Veliparib/Placebo Single-Agent Phase (Escalated)",
        "instanceType": "Administration",
        "dose": "400 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days 1 through 21 of a 21-day cycle (if 300 mg tolerated for 2 weeks)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Veliparib",
        "instanceType": "Substance",
        "description": "PARP inhibitor (ABT-888)"
      },
      {
        "id": "sub_2",
        "name": "Carboplatin",
        "instanceType": "Substance",
        "description": "Platinum-based chemotherapeutic agent"
      },
      {
        "id": "sub_3",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Taxane-based chemotherapeutic agent"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 15,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Veliparib (ABT-888)",
        "role": "Investigational Product",
        "description": "PARP inhibitor for HER2-negative metastatic or locally advanced unresectable BRCA-associated breast cancer."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for veliparib."
      },
      {
        "name": "Carboplatin",
        "role": "Background Therapy",
        "description": "Cytotoxic chemotherapy administered as reference therapy."
      },
      {
        "name": "Paclitaxel",
        "role": "Background Therapy",
        "description": "Cytotoxic chemotherapy administered as reference therapy."
      },
      {
        "name": "Corticosteroids",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "Diphenhydramine",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "H2 antagonists",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "Palonosetron",
        "role": "Concomitant Medication",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "name": "Dexamethasone",
        "role": "Concomitant Medication",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "name": "Aprepitant",
        "role": "Concomitant Medication",
        "description": "Optional antiemetic."
      },
      {
        "name": "G-CSF",
        "role": "Concomitant Medication",
        "description": "Colony stimulating factor permitted for supportive care or to maintain dose intensity."
      },
      {
        "name": "Bisphosphonates",
        "role": "Concomitant Medication",
        "description": "Permitted for osteoporosis or bone metastases management; prohibited for anti-cancer effect."
      },
      {
        "name": "Denosumab",
        "role": "Concomitant Medication",
        "description": "Permitted for management of bone metastases."
      },
      {
        "name": "Anticancer hormonal therapy",
        "role": "Concomitant Medication",
        "description": "Prohibited during the study; must be stopped 7 days before starting C1D-2."
      },
      {
        "name": "Chinese medicine/herbals",
        "role": "Concomitant Medication",
        "description": "Prohibited; requires a 14-day washout period."
      }
    ],
    "products": [
      {
        "name": "Veliparib",
        "doseForm": "Capsule",
        "strength": "Not specified",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Carboplatin",
        "doseForm": "Injection",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Injection",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Veliparib",
        "description": "PARP inhibitor (ABT-888)"
      },
      {
        "name": "Carboplatin",
        "description": "Platinum-based chemotherapeutic agent"
      },
      {
        "name": "Paclitaxel",
        "description": "Taxane-based chemotherapeutic agent"
      }
    ],
    "administrations": [
      {
        "name": "Veliparib/Placebo Combination Phase",
        "dose": "120 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days -2 through 5 of a 21-day cycle"
      },
      {
        "name": "Carboplatin",
        "dose": "AUC 6",
        "frequency": "once per cycle",
        "route": "Intravenous",
        "duration": "Day 1 of a 21-day cycle"
      },
      {
        "name": "Paclitaxel",
        "dose": "80 mg/m2",
        "frequency": "weekly",
        "route": "Intravenous",
        "duration": "Days 1, 8, and 15 of a 21-day cycle"
      },
      {
        "name": "Veliparib/Placebo Single-Agent Phase (Starting)",
        "dose": "300 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days 1 through 21 of a 21-day cycle"
      },
      {
        "name": "Veliparib/Placebo Single-Agent Phase (Escalated)",
        "dose": "400 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days 1 through 21 of a 21-day cycle (if 300 mg tolerated for 2 weeks)"
      }
    ],
    "devices": []
  }
}